PMC:7299399 / 30845-31016 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T136","span":{"begin":46,"end":51},"obj":"Body_part"},{"id":"T137","span":{"begin":125,"end":132},"obj":"Body_part"}],"attributes":[{"id":"A136","pred":"fma_id","subj":"T136","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A137","pred":"fma_id","subj":"T137","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"f immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T31","span":{"begin":137,"end":143},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"uberon_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"f immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T282","span":{"begin":46,"end":51},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T283","span":{"begin":137,"end":143},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"f immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T228","span":{"begin":2,"end":19},"obj":"Chemical"},{"id":"T229","span":{"begin":83,"end":87},"obj":"Chemical"},{"id":"T230","span":{"begin":94,"end":98},"obj":"Chemical"}],"attributes":[{"id":"A228","pred":"chebi_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/CHEBI_35705"},{"id":"A229","pred":"chebi_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A230","pred":"chebi_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"f immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}